首页> 美国卫生研究院文献>other >Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma
【2h】

Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma

机译:内含子剪接的可溶性B7-H3(sB7-H3)的特征和肝细胞癌患者血清中sB7-H3的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

B7-H3 is a recently discovered member of the B7 superfamily molecules and has been found to play a negative role in T cell responses. In this study, we identified a new B7-H3 isoform that is produced by alternative splicing from the forth intron of B7-H3 and encodes the sB7-H3 protein. Protein sequence analysis showed that sB7-H3 contains an additional four amino acids, encoded by the intron sequence, at the C-terminus compared to the ectodomain of 2Ig-B7-H3. We further found that this spliced sB7-H3 plays a negative regulatory role in T cell responses and serum sB7-H3 is higher in patients with hepatocellular carcinoma (HCC) than in healthy donors. Furthermore, we found that the expression of the spliced sb7-h3 gene is higher in carcinoma and peritumor tissues than in PBMCs of both healthy controls and patients, indicating that the high level of serum sB7-H3 in patients with HCC is caused by the increased expression of this newly discovered spliced sB7-H3 isoform in carcinoma and peritumor tissues.
机译:B7-H3是最近发现的B7超家族分子的成员,并且已发现在T细胞反应中起负作用。在这项研究中,我们确定了一种新的B7-H3同工型,它是由B7-H3的第4个内含子通过选择性剪接产生的,并编码sB7-H3蛋白。蛋白质序列分析表明,与2Ig-B7-H3的胞外域相比,sB7-H3在C端还包含内含子序列编码的另外四个氨基酸。我们进一步发现,这种剪接的sB7-H3在T细胞反应中起负调控作用,肝细胞癌(HCC)患者的血清sB7-H3高于健康供体。此外,我们发现剪接的sb7-h3基因在癌组织和癌旁组织中的表达均高于健康对照组和患者的PBMC,这表明HCC患者血清sB7-H3的高水平是由HCC升高引起的。新发现的剪接的sB7-H3亚型在癌组织和癌旁组织中的表达

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号